Viron, Inc.

About:

Viron is a Next-Generation Anti-Viral Technology Company. Viron C1, its first product, a prophylactic against Covid is under FDA review.

Website: http://www.vironinc.com

Description:

Viron Therapeutics Holdings Inc. is a Next-Generation Anti-Viral Technology Company. Viron C1, its first product, a prophylactic against Covid 19, is under FDA review.

Total Funding Amount:

$6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2019-01-01

Contact Email:

contact(AT)vironrx.com

Founders:

Bhanu Jena, Octavian Bucur

Number of Employees:

11-50

Last Funding Date:

2022-06-23

IPO Status:

Private

Industries: